REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Intelliseq S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Wholesale Trade Agents and Brokers | Data Processing, Hosting, and Related Services | Other Information Services | Internet Publishing and Broadcasting and Web Search Portals | All Other Information Services | Computer Systems Design and Related Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Intelliseq S.A. Profile Updated: May 20, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

intelliseq sp. z o.o. is a genome informatics company. The company has developed algorithms and bioinformatic tools for the interpretation of human DNA sequences. Their target market is focused on scientific research and genetic diagnosis processes. intelliseq sp. z o.o. offers genomic variant interpretation and clinical reporting capabilities, as well as alignment tools and algorithms for drug metabolism rates.

Headquarters
Ul. Stanislawa Konarskiego 42/13
Krakow; Malopolskie; Postal Code: 30-046

Contact Details: Purchase the Intelliseq S.A. report to view the information.

Website: http://www.intelliseq.pl

Basic Information
Outstanding Shares:
Purchase the Intelliseq S.A. report to view the information.
Registered Capital:
Purchase the Intelliseq S.A. report to view the information.
Incorporation Date:
December 31, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Company Performance
Financial values in the chart are available after Intelliseq S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-26.05%▼
Total operating revenue
-5.95%▼
Operating profit (EBIT)
-1057.48%▼
EBITDA
-1254.54%▼
Net Profit (Loss) for the Period
-1028.59%▼
Total assets
99.93%▲
Total equity
100.98%▲
Operating Profit Margin (ROS)
-687.13%▼
Net Profit Margin
-688.2%▼
Return on Equity (ROE)
-111.1%▼
Quick Ratio
0.46%▲
Cash Ratio
1.39%▲

Similar companies

Selvita S.A.
 
"Novo Nordisk Pharma" Sp. z o.o.
Celon S.A.
 
Mabion S.A.
Sartorius Stedim Poland Sp. z o.o.
 
Polpharma Biologics S.A.
Bioceltix S.A.
 
Coco Di Logistique Sp. z o.o.
Polbiotech Laboratorium Sp. z o.o.
 
Eversana Poland Sp. z o.o.
Food4Future Technologies Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo